logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Biologics Biosimilars And Biobetters An Introduction For Pharmacists Physicians And Other Health Practitioners Iqbal Ramzan

  • SKU: BELL-37231552
Biologics Biosimilars And Biobetters An Introduction For Pharmacists Physicians And Other Health Practitioners Iqbal Ramzan
$ 31.00 $ 45.00 (-31%)

4.8

84 reviews

Biologics Biosimilars And Biobetters An Introduction For Pharmacists Physicians And Other Health Practitioners Iqbal Ramzan instant download after payment.

Publisher: Wiley
File Extension: EPUB
File size: 9.8 MB
Pages: 320
Author: Iqbal Ramzan
ISBN: 9781119564652, 1119564654
Language: English
Year: 2021

Product desciption

Biologics Biosimilars And Biobetters An Introduction For Pharmacists Physicians And Other Health Practitioners Iqbal Ramzan by Iqbal Ramzan 9781119564652, 1119564654 instant download after payment.

A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective.

  • Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about
  • Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence
  • Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists

Related Products